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INTRODUCTION
Extracorporeal shock wave lithotripsy (ESWL) has
an established role in the management of pancreatic
ductal calculi. Combined with minimally invasive
endoscopic decompression, it has replaced open
surgery as the initial form of therapy. The principle of
operation involves the generation of shock waves in
or by reflection from an ellipsoid transducer. These
shock waves continuously increase in intensity due to
the large surface area of the human body, reaching
a maximum intensity within a 3 to 10 mm focal area.
Fragmentation rates with ESWL range from 75% to
100% and lead to complete stone clearance in 40–75%
patients.1-7 Risk factors for treatment failure include
multiple stones, the presence of strictures, and a large
stone burden. Although complete pancreatic stone
clearance is ideal, it is successful endoscopic
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ABSTRACT
Extracorporeal shock wave lithotripsy (ESWL) has an established role in the management of
pancreatic ductal calculi and as further treatment modality for large or difficult complicated common bile
duct (CBD) stones. Combined with minimally invasive endoscopic procedure such as endoscopic
retrograde cholangio-pancreatography (ERCP), it has replaced open surgery as the initial form of therapy.
ESWL has also proved to be an effective therapy in treating intrahepatic stones that are refractory to routine
endoscopic extraction. In these serial cases we present three cases which using combined ESWL and ERCP
procedures to treat chronic pancreatitis pain and giant CBD stone that presenting good results on follow
up without any complication.
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decompression with reduction in main ductal
diameters that is statistically correlated with pain
relief.1,5,8 Following treatment, complete pain relief and
a decrease in pain intensity was reported in 32-75%
and 65-100% of patients, respectively. ESWL
fragmentation of pancreatic ductal calculi in
conjunction with endoscopic clearance of the main
pancreatic duct is associated with significant
improvement in clinical outcomes in most patients with
chronic pancreatitis.9,10
ESWL is a further treatment modality for large
common bile duct (CBD) stones.11,12,13 Unlike
gallstones, for which the method was first applied in
the gastrointestinal tract, ultrasound scanning alone is
adequate for localizing the concretions in only two
thirds of patients. Before ESWL fragmentation,
endoscopic pretreatment with endoscopic retrograde
cholangio-pancreatography (ERCP), endoscopic
sphincterotomy, and implantation of a nasobiliary
catheter is universally mandatory. Today,
fragmentation is usually performed under
sedoanalgesia (e.g. midazolam and meperidine/
pethidine). In about 50% of cases, fragmentation can
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be performed under sonographic control, and in about
50% the instillation of diluted contrast medium is
necessary for successful stone localization and
control of the fragmentation process. Different single-
center studies have shown the efficacy of ESWL for
the treatment of large or impacted biliary calculi
refractory to endoscopic extraction. Stone clearance
rate was about 80% to 90% in series up to
310 patients; complications such as cholangitis or
hematoma were rarely observed.11,12,14 ESWL has also
proved to be an effective therapy in treating
intrahepatic stones that are refractory to routine
endoscopic extraction. In 55 patients, stone clearance
was achieved in 34% with ESWL alone and in 90%
when ESWL was combined with laser lithotripsy and
electrohydraulic lithotripsy (EHL).11,15 The
complication rate was 12%; all cases recovered with
conservative management.
CASES ILLUSTRATION
Case 1. ERCP and ESWL Management on Chronic
Pancreatitis with Multiple Pancreatic Duct Stones
A 12 year-old male patient referred to Cipto
Mangunkusumo hospital from Timika Papua with
chronic abdominal pain due to blunt trauma for 6 years.
Laboratory result showed hemoglobin 7.8 g/dL,
elevated ESR 145 mm/hour, amylase 1,088 U/L and
lipase 1,327 U/L level. Abdominal ultrasonography
(USG) showed pancreatitis with dilated pancreatic duct
and intraductal multiple stones. Abdominal CT
findings revealed chronic pancreatitis and calcification
within pancreas. An ERCP procedure was done.
After cannulation of main pancreatic duct and
injecting contrast, the pancreatogram showed multiple
dilatations and intraductal stones which the largest
stone positioned in main pancreatic duct of the head
of pancreas. We did plastic pancreatic stent placement
in main pancreatic duct and proceed the patient for
ESWL procedure to crush the stones. After ESWL
crushing, a plain X-ray showed the stones becoming
fragmented and a second ERCP procedure was done
to extract the fragmented stones especially the largest
group at the head area. We did endoscopic pancreatic
sphincterotomy (EPS) and extracted fragmented stones
using dormia basket, some stones easily discharge.
After these procedures of ERCP and ESWL
management, the patient really in good condition, free
of pain, and the amylase and lipase level becoming
normal (96 and 27 U/L respectively).
Case 2. ERCP and ESWL Management on Chronic
Calcific Pancreatitis with Mean Pancreatic Duct
Dilation Presenting by Chronic Upper Abdominal Pain
A 42 year old male patient came to Gastro-
enterology Clinic Cipto Mangunkusumo hospital
suffering upper abdominal pain especially since
six months before admission. He has no history of
alcohol consumption neither also smoking. There was
only epigastric tenderness pain on physical
examination. Laboratory result s showed erythrocytes
sediment rate (ESR) 20 mm/hour, white blood cell
count (WBC) 5,900/mL, platelets 221,000/mL, serum
amylase 23 U/L, serum lipase 23 U/L. We found no
significant abnormalities on upper and lower gastro-
intestinal endoscopies. Magnetic resonance cholangio-
pancreatography (MRCP) showed dilated mean
pancreatic duct (MPD) with multiple calcification.
An ERCP performed and showed MPD dilatation with
multiple pancreatic stones especially at head area.
A plastic pancreatic stent placement was done and then
the patient proceeds to department of urology to get
ESWL procedure to crush the stones. After 2 series of
ESWL procedures, repeated ERCP was done to
extract multiple fragmented pancreatic stones
using small dormia basket after performing EPS.
Many within plugs proteins came out discharging.
Laboratory results post stones extraction showed
amylase 36 U/L and lipase 25 U/L. The patient
immediately free of pain after these procedures.
Case 3. ERCP and ESWL Management on Difficult
Bile Duct Stones
A 49 year old female patient came to
the Emergency Unit of Cipto Mangunkusumo
hospital due to yellowish eyes and whole body skin
since four days before admission. She had also
nausea, epigastric pain, dark yellow urine, pale stool
and fever. Her blood pressure 110/60 mmHg, heart
rate 110/minute, respiratory rate 22/minute, tempera-
ture 38°C. Conjunctiva was pale, icteric sclera, and
hepatomegaly. Laboratory results showed hemoglobin
6.5 g/dL, WBC 16,800/mL, platelets 586,000/mL, AST
116 U/L, ALT 93 U/L, gGT 410 U/L, ALP 1,506 U/L,
total protein 5.3 g/dL, albumin 1.8 g/dL, total
bilirubin 38.1 mg/dL, direct bilirubin 31.9 mg/dL and
indirect bilirubin 6.11 mg/dL. No ECG and CXR
abnormalities. Abdominal USG showed dilatation of
CBD suggestive bile duct stone in distal CBD with no
stone in the gallbladder. An ERCP procedure was done
which showed mobile giant stone 30 mm x 20 mm in
CBD, then a plastic stent 7 fr - 10 cm was placed at
hilar of common hepatic duct. A 2 series of ESWL
procedure, were done to the patient to crush
the stone and then ERCP was done again to extract
multiple fragmented stones using dormia basket and
balloon extraction. After procedures the patient
condition becoming well, no fever. Laboratory results
showed hemoglobin 10.2 g/dL, white blood cell
10,000/mL, total bilirubin 2.22 mg/dL, direct
bilirubin 2.31 mg/dL, indirect bilirubin 0.09 mg/dL and
albumin 3.3 g/dL.
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Figure 2. Multiple pancreatic duct stones with dilated mean
pancreatic duct
Figure 3. Giant mobile bile duct stone becoming fragmented after crushed by
ESWL and then extracted with dormia basket
Figure 1. Pancreatic stent placement followed by crushing stones with ESWL
and pancreatic duct stones extraction with dormia basket
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DISCUSSION
The use of ERCP in combination with ESWL
techniques has become increasingly common in
patients with chronic pancreatitis and complicated
common bile duct stones. Chronic pancreatitis (CP) is
a progressive disease for which there is no curative
treatment. Therapeutic efforts have therefore centered
on palliative treatment of the severe pain associated
with this condition.16 Relief of pain is the main
indication of endotherapy of chronic pancreatitis.
The pathogenesis of the pain is still poorly
understood. The mechanism most widely thought to
be responsible is the increased pancreatic
parenchymal pressure. This pressure is secondary to
increased ductal pressure resulting from an outflow
obstruction caused by strictures, pancreatic stones, or
compressing pseudocysts and to a reduced
parenchymal compliance caused by fibrosis.16,17,18
Though pathogenesis of pain in chronic
pancreatitis is poorly understood and is considered
multifactorial, ductal hypertension accounts for
major component of pain. Pancreatic ductal blockade
due to strictures and stones and decreased
parenchymal compliance because of fibrosis leads to
increased intraglandular pressure and ischemia
resulting in pain.19,20 Relief of pain in 70% to 90% of
cases following endoscopic or surgical decompressive
procedures supports this theory. Whether early ductal
drainage changes the natural history of progressive
exocrine and endocrine dysfunction is not certain.
There is some experimental19,21 and clinical evidence19,22
of these collateral benefits.
In patients with CP, the favorable results of
surgical and endoscopic decompressive procedures that
relieve pain in 70% to 90% of cases23,24 support
the possibility that ductal obstruction triggers this pain.
Furthermore, it has been shown that recurrent pain
attacks after ductal decompression procedures are
usually caused by recurrent ductal obstruction.2 When
the pancreas lacks compliance, ductal hypertension
induces tissue hypertension that impairs blood flow
and may cause ischemia.20 In an experimental model
of CP resulting in increased intraductal pressure, it was
observed that the reduction in pancreatic blood flow
was partially reversed after relief of the obstruction of
the main pancreatic duct (MPD) by surgical drainage
or by ductal stenting.25 In the same model, pancreatico-
jejunostomy improved the pancreatic blood flow more
in early CP than in established CP26 under both basal
and stimulated secretory conditions, indicating that an
earlier treatment of the pain symptoms might be
beneficial for long-term outcome.16
Successful of stones extraction after
sphincterotomy depends on size, number, location and
presence of associated strictures. Stones < 10 mm
located in head and body and three or less in number
had greater clearance rate.19,27 In single center
retrospective study of 125 patients of chronic
pancreatitis with ductal stones28 had 85% technical
success rate with complete ductal clearance in 50/125
and partial in 55/125 cases. ESWL was needed in 91%
cases in addition. Regular stent exchanges were needed
in 70 patients. No serious complications were reported.
Eighty-five patients had a mean follow up of 29 months
and nearly half remain pain free. Repeated endotherapy
in rest could achieve 93% clinical success rate. Only
15 patients needed elective surgery. Middle age, stones
near ampulla and early stage of chronic pancreatitis
were associated with higher ductal clearance rate on
univariate analysis.19
ESWL was found to be the best independent
predictive factor for MPD clearance on multivariate
analysis of 70 patients.4,19 ESWL alone without
pancreatic sphincterotomy could attain ductal
clearance in 24/32 (75%) patients. Twenty two
patients in this series had no strictures and only 2/32
had overt exocrine insufficiency. Fifty percent patients
relapse within 1 year follow up.19,29
The aims of therapeutic endoscopy in CP include:
(1) pancreatic ductal drainage in patients with chronic
pain or recurrent attacks of pancreatitis, a procedure
which can be performed soon after the onset of
symptoms; (2) the treatment of complications such as
pseudocyst and biliary obstruction. Whether
immediate treatment can change the natural history of
progressive loss of exocrine and endocrine function is
still not known, even though experimental21 and
clinical22 evidence suggests that ductal decompression
may be beneficial in modulating CP outcome.16
ESWL can also be used for giant CBD stones not
amenable to regular ERCP or mechanical lithotripsy.
The latest models of ESWL are more patient-friendly
and the procedure can be performed under sedation.
ERCP and papillotomy are still required in most cases
for localization of the stones. A nasobiliary catheter is
placed for cholangiography. Alternatively,
percutaneous cholangiography can be employed for
stone localization. Even if fragmentation by ESWL is
successful, the resultant stone fragments are often too
big to pass out spontaneously and must be removed by
either ERCP or percutaneous cholangioscopy.30 There
are many studies reporting high ductal clearance rates.
In a multicenter study conducted in Germany,
the success rate was 86%, with a mortality rate of
only 1.8%.30,31 Other series also reported similar
outcomes, with cholangitis being the most frequent
complication. The most recent report by Ellis et al
studied 83 patients with retained bile duct stones treated
by the third-generation lithotriptor.12 Complete stone
clearance was achieved in 69 (83%) patients.
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Complications included six cases of cholangitis, and
one perinephric hematoma which resolved
spontaneously.12,30 Amplatz et al found and concluded
that ESWL is a safe and effective therapy in those
patients in whom endoscopic techniques have failed
with a clearing rate of 90.2% of refractory bile duct
stones with a low rate of complications. Complications
were recorded in 34 patients (9.1%); 22 patients
experienced symptomatic cardiac arrhythmia, four
hemobilia, two cholangitis, three hematuria, 3 dyspnea;
no deaths were associated with the procedure.32
Here in this serial cases report, we also
successfully did combining ERCP and ESWL
procedures in treating chronic pancreatitis pain and giant
CBD stone with good results.
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